DocDollars

Sanofi-Aventis U.S. LLC

NJ · United States · Reporting entity ID 100000000076

Total reported 2019–2025
$86.8M
#110 of 2,960 reporting companies — 0.1% of all reported industry payments
$58.8M in general payments across 478,342 records, plus $28.0M in research funding across 2,321 records.

How it breaks down

General payments $58,814,903
Research funding $27,950,478

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Sanofi-Aventis U.S. LLC reported $86.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #110 of 2,960 reporting companies. 32% of that was research funding and 68% general payments such as consulting, speaking, food and travel. 478,342 general payment records and 2,321 research records were filed.

Common questions about Sanofi-Aventis U.S. LLC

How much has Sanofi-Aventis U.S. LLC paid US doctors?

Sanofi-Aventis U.S. LLC reported $86,765,381 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $58,814,903 in general payments, $27,950,478 in research funding.

How does Sanofi-Aventis U.S. LLC rank among drug and device companies?

It ranks #110 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Sanofi-Aventis U.S. LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.